ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Atherosclerosis"

  • Abstract Number: 1658 • ACR Convergence 2020

    Mediation of the Association Between Obesity and Osteoarthritis by Blood Pressure, Arterial Stiffness, and Subclinical Atherosclerosis

    Marieke Loef1, Rob van der Geest1, Hildo Lamb1, Renée de Mutsert1, Frits Rosendaal1 and Margreet Kloppenburg1, 1Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Obesity-related metabolic dysregulation may lead to atherosclerotic vascular changes. It has been hypothesized that a compromised blood flow may cause detrimental changes to the…
  • Abstract Number: 0290 • ACR Convergence 2020

    Role of Protein Tyrosine Phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) Promoted by Inflammation: Implications for SLE

    Jorge Romo-Tena1, José Esparza-López2, Carmelo Carmona-Rivera3, Luz Blanco4, Mariana Kaplan3 and María de Jesús Ibarra-Sánchez2, 1NIAMS, National Institute of Health, Bethesda, 2INNSZ / UNAM-RAI, Mexico City, Mexico, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Centreville

    Background/Purpose: The endothelial-to-mesenchymal transition (EndoMT) transdifferentiation process can be promoted by several proinflammatory mediators in many pathological conditions. Recently, it was suggested a crucial role…
  • Abstract Number: 1811 • ACR Convergence 2020

    Distinctive Molecular Signatures Among Monocytes from Childhood- and Adult-onset Systemic Lupus Erythematosus: Clinical Involvement and Relevance of Sustained Anti-dsDNA Positivity

    Alejandra Maria Patiño-Trives1, Concepción Aranda-Valera2, R Roldan3, Laura Pérez-Sanchez4, Carlos Pérez-Sánchez1, Maria Luque-Tevar1, Iván Arias de la Rosa1, María-Carmen Abalos-Aguilera1, Desirée Ruiz-Vilchez2, Pedro Segui5, Mario Espinosa5, Nuria Barbarroja1, Eduardo Collantes2, María de los ángeles Aguirre-Zamorano5 and Chary Lopez-Pedrera1, 1Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Cordoba, Spain, 2Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 3Hospital Universitario Reina Sofía, Cordoba, Spain, 4Hospital Universitario Reina Sofía, Córdoba, Spain, 5IMIBIC/University of Cordoba/Reina Sofia Hospital, Cordoba

    Background/Purpose: By using integrative transcriptomic and protein analyses, this study aimed at identifying and characterize distinctive molecular signatures between childhood-onset (cSLE) and adult-onset Lupus (aSLE)…
  • Abstract Number: 0472 • ACR Convergence 2020

    ApoB:ApoA1 Ratio Could Predict Atherosclerotic Risk in Juvenile-SLE Patients Associated with Altered Interferon Signalling in CD8+ T-cells

    George Robinson1, Kirsty Waddington2, Leda Coelewij2, Junjie Peng2, Meena Naja2, Chris Wincup2, Anna Radziszewska2, Hannah Peckham2, David Isenberg2, Yiannis Ioannou2, Ines Pineda Torra2, Coziana Ciurtin2 and Elizabeth Jury2, 1University College London, Hertford, United Kingdom, 2University College London, London, United Kingdom

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterised by immune-dysregulation, chronic inflammation, type-I interferon (IFN) signatures and increased cardiovascular disease (CVD) risk…
  • Abstract Number: 0485 • ACR Convergence 2020

    Non-obese Rheumatoid Arthritis Patients with Low Low-density Lipoprotein Have Higher Coronary Atherosclerosis Burden, Greater Plaque Progression and Cardiovascular Event Risk

    George Karpouzas1, Sarah Ormseth1, Elizabeth Hernandez1 and Matthew Budoff1, 1Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA

    Background/Purpose: RA patients with low body weight incur higher mortality than obese patients. Paradoxically, RA patients in the lowest low-density lipoprotein group (LDL < 70…
  • Abstract Number: 0486 • ACR Convergence 2020

    Differences in Low-density Lipoprotein (LDL) Particle Composition and Oxidation May Underlie the Paradoxical Association of Low LDL with Higher Coronary Atherosclerosis Burden in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth1, Elizabeth Hernandez1 and Matthew Budoff1, 1Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA

    Background/Purpose: Rheumatoid arthritis (RA) patients in the lowest LDL group (< 70mg/dl) experience unexpectedly high cardiovascular risk. We first explored whether this group (Group 1)…
  • Abstract Number: 0671 • ACR Convergence 2020

    Structured Cardiovascular Assessment in Gout Incorporating Carotid Ultrasound: Analysis of Subsequent Events in the Follow-Up

    Mar Monzó1, Neus Quilis2, Laura Ranieri2, Alejandro San-Martín3 and Mariano Andrés4, 1Universidad Miguel Hernández, Alicante, Spain, 2Hospital Universitario del Vinalopó, Alicante, Spain, 3Clínica HLA Vistahermosa, Alicante, Spain, 4Hospital General Universitario de Alicante-ISABIAL and Universidad Miguel Hernández de Elche, Alicante, Spain

    Background/Purpose: Gout is an independent cardiovascular (CV) risk factor. This excess of morbidity and mortality requires optimal management, especially in high-risk individuals. Therefore, the inclusion…
  • Abstract Number: 0789 • ACR Convergence 2020

    Matrix Gla Protein (MGP) Modified with Malondialdehyde/Acetaldehyde Is Increased in Rheumatoid Arthritis and Cardiovascular Patients

    Xiarepati Tieliwaerdi1, Nozima Aripova1, Michael Duryee1, Xiaoting Jiang1, Lynell Klassen2, James O'Dell1, Bryant England1, Daniel Anderson1, Ted Mikuls1 and Geoffrey Thiele1, 1University of Nebraska Medical Center, Omaha, NE, 2Univerisity of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) burden, dramatically increasing the risk of mortality. Circulating antibodies to Malondialdehyde-Acetaldehyde (MAA) modified…
  • Abstract Number: 0870 • ACR Convergence 2020

    Hydroxychloroquine Is Associated with Lower Platelet Activity and Improved Vascular Health in Systemic Lupus Erythematosus

    Michael Golpanian1, Elliot Luttrell-Williams2, MacIntosh Cornwell2, Khrystyna Myndzar2, Hanane El Bannoudi2, Ashira Blazer2, Stuart Katz2, Nathaniel Smilowitz2, Kelly Ruggles2, Robert Clancy3, Jill Buyon4 and Jeffrey Berger2, 1New York University, New York, NY, 2New York University School of Medicine, New York, 3NYU School of Medicine, New York, 4Department of Medicine, NYU School of Medicine, New York, NY

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) are at increased risk of premature atherosclerosis and thrombosis. Hydroxychloroquine (HCQ) is widely used in the treatment of…
  • Abstract Number: 1178 • ACR Convergence 2020

    Associations of Walking Endurance and Speed with Multiple Measures of Subclinical Cardiovascular Disease in Rheumatoid Arthritis

    Genna Braverman1, Sabahat Bokhari2, Kazato Ito3, Joan Bathon2 and Jon Giles4, 1NY Presbyterian - Columbia University Irving Medical Center, New York, NY, 2Columbia University, Vagelos College of Physicians and Surgeons, New York, NY, 3Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 4Columbia University, New York, NY

    Background/Purpose: The 400 meter timed walk test has been studied as a simple summary measure of fitness that is predictive of mobility limitation and incident…
  • Abstract Number: 1182 • ACR Convergence 2020

    Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Mayra Alejandra Reyes Soto3, Alejandra Pérez Villar3, Itzel Corina Zárate Salinas2, Paola Fernanda Frausto Lerma3 and Salvador Lugo Pérez2, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico

    Background/Purpose: Cardiovascular disease (CVD) is the primary cause of mortality in women in developed countries. CVD risk rises with age, yet for women there is…
  • Abstract Number: 1192 • ACR Convergence 2020

    Subclinical Coronary Calcification Associated with Long-term Cardiovascular Outcomes in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth1, Elizabeth Hernandez1 and Matthew Budoff1, 1Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA

    Background/Purpose: Large, multicenter studies established the strong prognostic value of coronary artery calcium (CAC) scoring in asymptomatic individuals. Increasing CAC score is an independent predictor…
  • Abstract Number: 1205 • ACR Convergence 2020

    Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of One-year Anti-TNF-α Therapy

    Anita Pusztai1, Attila Hamar2, Ágnes Horváth2, Katalin Gulyás2, Edit Végh2, Nóra Bodnár2, György Kerekes2, Monika Czókolyová2, Szilvia Szamosi2, Levente Bodoki2, Katalin Hodosi2, Andrea Domján2, Gábor Nagy2, Luis Lopez3, Ejii Matsuura4, Zoltán Prohászka5, Sándor Szántó2, Zoltán Nagy2, Yehuda Shoenfeld6, Zoltán Szekanecz2 and Gabriella Szűcs2, 1University of Debrecen Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary, 2University of Debrecen, Debrecen, Hungary, 3Corgenix Inc., Broomfield, CO, 4Okayama University, Okayama, Japan, 5Semmelweis University, Budapest, Hungary, 6Zabludowicz Center, Tel-Hashomer, Israel

    Background/Purpose: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have been associated with cardiovascular (CV) disease. The treatment of arthritis by tumour necrosis factor α (TNF-α)…
  • Abstract Number: 1329 • ACR Convergence 2020

    Subclinical Atherosclerosis Risk in Psoriatic Arthritis: Could It Be Prevented?

    Mai Farouk1, Salwa Moussa1 and Rowaida Abdou1, 1Rhuematology Ain Shams University Hospitals, Cairo, Egypt

    Background/Purpose: Psoriatic arthritis (PsA) is an immune-mediated inflammatory arthritis associated with psoriasis that can cause remarkable joint damage (1). Subclinical cardiovascular disease (CVD) due to…
  • Abstract Number: 622 • 2019 ACR/ARP Annual Meeting

    Ten-year Atherosclerotic Cardiovascular Disease Risk Scores in Axial Spondyloarthritis versus the General Population: A Cross-sectional Study

    Jean Liew1, John Reveille 2, Henna Sawhney 3, Maria Castillo 3, Benjamin Naovarat 4, Susan Heckbert 1 and Lianne Gensler 5, 1University of Washington, Seattle, WA, 2University of Texas McGovern Medical School, Houston, 3University of California in San Francisco, San Francisco, CA, 4University of Texas-McGovern Medical School, Houston, TX, 5University San Francisco California, San Francisco, CA

    Background/Purpose: Cardiovascular morbidity and mortality are increased in axial spondyloarthritis (axSpA). The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend high intensity statin…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology